ロード中...
Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy
<p><strong>Background.</strong> Therapy for metastatic castration-resistant prostate cancer (CRPC) is a serious problem that requires significant public health care expenditures.</p><p><strong>Objective</strong>: to evaluate the cost-effectiveness of abirate...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
ABV-press
2014-11-01
|
| シリーズ: | Onkourologiâ |
| 主題: | |
| オンライン･アクセス: | http://oncourology.abvpress.ru/index.php/oncur/article/view/383 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|